[Pharmacogenetic testing in the clinical setting: is screening for TPMT genotype a cost-effective treatment strategy? The first prospective randomized controlled trial within the Dutch health care system]

ZonMW
Record ID 32006001365
Dutch
Details
Project Status: Completed
URL for project: http://www.zonmw.nl
Year Published: 2013
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Netherlands
MeSH Terms
  • Cost-Benefit Analysis
  • Genotype
  • Polymorphism, Genetic
  • Pharmacogenomic Testing
  • Methyltransferases
  • Pharmacogenetics
Contact
Organisation Name: The Netherlands Organisation for Health Research and Development
Contact Address: The Netherlands Organisation for Health Research and Development PO Box 93245 2509 AE The Hague The Netherlands Tel: +31 70 349 5111 Fax: +31 70 349 5100
Contact Name: info@zonmw.nl
Contact Email: info@zonmw.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.